• 10074-G5: Applied Workflows for Targeted c-Myc Inhibition

  2026-04-25

  10074-G5, a potent c-Myc inhibitor from APExBIO, empowers translational cancer research with validated workflows for apoptosis assays, cell cycle arrest, and tumor regression studies. This guide details protocol enhancements, troubleshooting strategies, and practical insights for leveraging 10074-G5 in advanced oncology experiments.

• Analytical Methods for Rotigotine: Ensuring Quality in PD Re

  2026-04-24

  This review systematically evaluates state-of-the-art analytical techniques for Rotigotine, a dopamine D2/D3 receptor agonist, with focus on raw material, pharmaceutical formulations, and impurity profiling. The article highlights the critical role of chromatographic methods in quality control and discusses the implications for stability and reproducibility in Parkinson’s disease research.

• Strategic Metabolic Modulation: From Bench to Bedside

  2026-04-24

  This thought-leadership article dissects the mechanistic and translational landscape of metabolism-focused small molecule research. By drawing on clinical insights from propranolol’s modulation of post-burn hypermetabolism and integrating practical guidance for metabolic enzyme inhibition assays, it positions the DiscoveryProbe™ Metabolism-related Compound Library as a pivotal tool in accelerating discoveries from pathway to patient impact. Unique to this piece is the strategic synthesis of evidence, protocol optimization, and forward-looking perspectives for translational researchers.

• Plerixafor (AMD3100): Applied CXCR4 Inhibition in Cancer and

  2026-04-23

  Plerixafor (AMD3100) empowers researchers to dissect CXCL12/CXCR4 signaling for robust cancer metastasis inhibition and hematopoietic stem cell mobilization. This guide translates recent comparative findings and hands-on protocol refinements into actionable workflows, with troubleshooting strategies to maximize reproducibility and impact.

• Propidium Iodide: Advanced DNA Intercalating Dye for Cell An

  2026-04-23

  Propidium iodide from APExBIO delivers gold-standard specificity for cell viability, apoptosis, and cell cycle assays. This guide translates recent cancer research and expert workflow optimizations into actionable protocols, troubleshooting strategies, and comparative insights to maximize your experimental outcomes.

• Perphenazine: Mechanistic Insights for Host-Directed Therapi

  2026-04-22

  Explore how Perphenazine, a potent dopamine D2 receptor antagonist, enables host-directed antibacterial strategies and innovative neuropharmacology research. This article delivers a deep mechanistic analysis and practical guidance not found in prior reviews.

• Organic Cation Transporters and Xenobiotic Clearance in Aede

  2026-04-22

  Kennel and Rouhier's 2025 study probes how Aedes aegypti mosquitoes express putative organic cation transporters (OCTs/OCTNs) and clear xenobiotic dyes, including olsalazine. Their work identifies nuanced transporter responses and altered excretion profiles, informing potential molecular targets for mosquito control and advancing understanding of xenobiotic handling in disease vectors.

• Sulfo-Cy3 NHS Ester: Precision Labeling for Complex Proteome

  2026-04-21

  Explore how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, enables quantitative and artifact-resistant labeling of challenging proteins and peptides. This article uniquely bridges advanced bioconjugation chemistry with emerging vascular biology insights, offering a deeper scientific perspective for researchers.

• Canagliflozin: Mitochondrial Remodeling and Experimental Des

  2026-04-21

  Explore how Canagliflozin, a leading SGLT2 inhibitor, uniquely remodels renal mitochondrial networks and shapes experimental protocols in diabetes research. This article offers deep insights, practical assay guidance, and a new dimension to metabolic disease modeling.

• G007-LK Tankyrase 1/2 Inhibitor: Precision for Colorectal Ca

  2026-04-20

  G007-LK delivers nanomolar potency for targeted Wnt/β-catenin pathway inhibition, supporting advanced APC mutation colorectal cancer research. Discover its workflow integration, troubleshooting strategies, and the translational edge from recent hepatocellular carcinoma studies.

• HIV-1 Infection Sensitizes Brain Pericytes to Glutamate-Indu

  2026-04-20

  This study explores how HIV-1 infection and latency compromise the DNA damage response in brain vascular pericytes, increasing their vulnerability to neuroinflammatory stimuli such as extracellular glutamate. These findings highlight a potential mechanism for blood-brain barrier disruption in HIV-associated neurocognitive disorders and point toward new avenues for DNA repair research.

• TSPAN18 Stabilizes STIM1: New Insights into Prostate Cancer

  2026-04-19

  This article reviews Zhou et al.'s discovery that TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, enhancing Ca2+ signaling and promoting bone metastasis in prostate cancer. The findings define a novel regulatory axis and present TSPAN18 as a promising therapeutic target for metastatic disease.

• JAK Inhibitors and Endothelial Dysfunction: Comparative Effe

  2026-04-18

  This study systematically compares the vascular effects of approved JAK inhibitors, including Tofacitinib citrate (CP-690550 citrate), on endothelial cells exposed to proinflammatory cytokines. Findings reveal key differences in inflammatory and procoagulant responses, informing experimental design and cardiovascular risk assessment in immune regulation research.

• Ellagic Acid: Potent CK2 Inhibitor for Cancer Biology Resear

  2026-04-17

  Ellagic acid (2,3,7,8-tetrahydroxychromeno chromene dione) is a selective ATP-competitive inhibitor of casein kinase 2 (CK2), widely used in cancer biology research and oxidative stress assays. Its high specificity, robust antitumor activity, and stringent storage requirements make it a cornerstone reagent for apoptosis and CK2 pathway studies.

• AT13387: Precision Hsp90 Inhibition for Cancer Biology Resea

  2026-04-16

  AT13387 empowers cancer researchers with nanomolar potency, tumor-selective retention, and a robust workflow for dissecting apoptosis and oncogenic signaling. This review synthesizes advanced protocol guidance with insights from breakthrough apoptosis studies, positioning AT13387 as a next-generation Hsp90 inhibitor for translational research.

446 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page